News Gatherer
Community Support Team
|
|
Join Date: Dec 2007
Posts: 65,355
|
|
News Gatherer
Community Support Team
Join Date: Dec 2007
Posts: 65,355
|
International Stem Cell Corporation Announces Third Patient with Parkinson's Disease
International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial
Yahoo Finance
The Phase I clinical study is a dose escalation safety and preliminary efficacy study of ISC-hpNSC®, intracranially transplanted into patients with moderate to severe Parkinson's disease. The open-label, single center, uncontrolled clinical trial will ...
and more »
More...
|